Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
TSE:4572
Price:
436 JPY
-1.13%
Updated:
May 9, 2024
P/E
Price to Earnings
Price to Earnings
-6.6
Current
-8.2
Median
31.1
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-6.6
Market Cap
/
7.6B
Net Income
-1.2B
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
|
Carna Biosciences Inc
TSE:4572
|
7.6B JPY | -6.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 37 | |
| US |
|
Danaher Corp
NYSE:DHR
|
184.8B USD | 22.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
41.8B USD | 33.9 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38B CHF | 58 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD | 30.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 64.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 34.2 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 47.1 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.8B USD | 37.7 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.8B EUR | 73.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
